Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®

NCT04479020 is registered in ClinicalTrials.gov with Acandis GmbH as lead sponsor.

NCT NCT04479020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04479020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REcanalization of Distal Cerebral Vessels in Acute Stroke Using ApeRio®
Lead sponsor
Acandis GmbH
Phase
Observational
Overall status
Completed
Start date
July 1, 2020
Completion date
May 1, 2024
Enrollment
134 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

acute stroke